Laboratory analysis of valsartan products
FDA continues to investigate the presence of impurities in valsartan products and other angiotensin II receptor blockers (ARBs) used to treat high blood pressure and heart failure.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Cardiology | Diovan | Drugs & Pharmacology | Heart | Heart Failure | Hypertension | Laboratory Medicine